We have developed the most efficient approach for RNA-seq library synthesis.

RNA sequencing is vital for cutting-edge cancer diagnostics, pharmaceutical development, and food security, but the time and cost are major bottlenecks. At Amaryllis Nucleics, our technology breaks down these barriers by cutting time and cost manyfold — empowering researchers and accelerating important discoveries in genomics.

  An  IndieBio  portfolio company

An IndieBio portfolio company